252 related articles for article (PubMed ID: 20802348)
1. Stromal macrophage expressing CD204 is associated with tumor aggressiveness in lung adenocarcinoma.
Ohtaki Y; Ishii G; Nagai K; Ashimine S; Kuwata T; Hishida T; Nishimura M; Yoshida J; Takeyoshi I; Ochiai A
J Thorac Oncol; 2010 Oct; 5(10):1507-15. PubMed ID: 20802348
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of CD204-positive macrophages in lung squamous cell carcinoma: possible contribution of Cd204-positive macrophages to the tumor-promoting microenvironment.
Hirayama S; Ishii G; Nagai K; Ono S; Kojima M; Yamauchi C; Aokage K; Hishida T; Yoshida J; Suzuki K; Ochiai A
J Thorac Oncol; 2012 Dec; 7(12):1790-1797. PubMed ID: 23154550
[TBL] [Abstract][Full Text] [Related]
3. The intratumoral distribution influences the prognostic impact of CD68- and CD204-positive macrophages in non-small cell lung cancer.
Li Z; Maeda D; Yoshida M; Umakoshi M; Nanjo H; Shiraishi K; Saito M; Kohno T; Konno H; Saito H; Minamiya Y; Goto A
Lung Cancer; 2018 Sep; 123():127-135. PubMed ID: 30089583
[TBL] [Abstract][Full Text] [Related]
4. Relationship between stromal cells and tumor spread through air spaces in lung adenocarcinoma.
Qiu X; Chen D; Liu Y; Duan S; Zhang F; Zhang Y; Li F; Chen C; Chen Y
Thorac Cancer; 2019 Feb; 10(2):256-267. PubMed ID: 30605235
[TBL] [Abstract][Full Text] [Related]
5. Tumor-Associated CD204-Positive Macrophage Is a Prognostic Marker in Clinical Stage I Lung Adenocarcinoma.
Sun Y; Xu S
Biomed Res Int; 2018; 2018():8459193. PubMed ID: 29850577
[TBL] [Abstract][Full Text] [Related]
6. Circulating CD14+CD204+ cells predict postoperative recurrence in non-small-cell lung cancer patients.
Maeda R; Ishii G; Neri S; Aoyagi K; Haga H; Sasaki H; Nagai K; Ochiai A
J Thorac Oncol; 2014 Feb; 9(2):179-88. PubMed ID: 24419414
[TBL] [Abstract][Full Text] [Related]
7. Tumor associated macrophage expressing CD204 is associated with tumor aggressiveness of esophageal squamous cell carcinoma.
Shigeoka M; Urakawa N; Nakamura T; Nishio M; Watajima T; Kuroda D; Komori T; Kakeji Y; Semba S; Yokozaki H
Cancer Sci; 2013 Aug; 104(8):1112-9. PubMed ID: 23648122
[TBL] [Abstract][Full Text] [Related]
8. Link between tumor-promoting fibrous microenvironment and an immunosuppressive microenvironment in stage I lung adenocarcinoma.
Sakai T; Aokage K; Neri S; Nakamura H; Nomura S; Tane K; Miyoshi T; Sugano M; Kojima M; Fujii S; Kuwata T; Ochiai A; Iyoda A; Tsuboi M; Ishii G
Lung Cancer; 2018 Dec; 126():64-71. PubMed ID: 30527194
[TBL] [Abstract][Full Text] [Related]
9. The association of intravascular stromal cells with prognosis in high-grade neuroendocrine carcinoma of the lung.
Sekihara K; Hishida T; Ikemura S; Saruwatari K; Morise M; Kuwata T; Fujii S; Kojima M; Ochiai A; Funai K; Aokage K; Yoshida J; Tsuboi M; Ishii G
J Cancer Res Clin Oncol; 2016 May; 142(5):905-12. PubMed ID: 26696594
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of cancer-associated stromal cells in patients with stage I lung adenocarcinoma.
Ito M; Ishii G; Nagai K; Maeda R; Nakano Y; Ochiai A
Chest; 2012 Jul; 142(1):151-158. PubMed ID: 22302300
[TBL] [Abstract][Full Text] [Related]
11. Low density of CD204-positive M2-type tumor-associated macrophages in Epstein-Barr virus-associated gastric cancer: a clinicopathologic study with digital image analysis.
Ichimura T; Abe H; Morikawa T; Yamashita H; Ishikawa S; Ushiku T; Seto Y; Fukayama M
Hum Pathol; 2016 Oct; 56():74-80. PubMed ID: 27342912
[TBL] [Abstract][Full Text] [Related]
12. Identification of biological properties of intralymphatic tumor related to the development of lymph node metastasis in lung adenocarcinoma.
Kirita K; Ishii G; Matsuwaki R; Matsumura Y; Umemura S; Matsumoto S; Yoh K; Niho S; Goto K; Ohmatsu H; Ohe Y; Nagai K; Ochiai A
PLoS One; 2013; 8(12):e83537. PubMed ID: 24376714
[TBL] [Abstract][Full Text] [Related]
13. Abundant tumor promoting stromal cells in lung adenocarcinoma with hypoxic regions.
Nakamura H; Ichikawa T; Nakasone S; Miyoshi T; Sugano M; Kojima M; Fujii S; Ochiai A; Kuwata T; Aokage K; Suzuki K; Tsuboi M; Ishii G
Lung Cancer; 2018 Jan; 115():56-63. PubMed ID: 29290263
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-17 and prostaglandin E2 are involved in formation of an M2 macrophage-dominant microenvironment in lung cancer.
Liu L; Ge D; Ma L; Mei J; Liu S; Zhang Q; Ren F; Liao H; Pu Q; Wang T; You Z
J Thorac Oncol; 2012 Jul; 7(7):1091-100. PubMed ID: 22534817
[TBL] [Abstract][Full Text] [Related]
15. Tumor-associated CD204
Kawachi A; Yoshida H; Kitano S; Ino Y; Kato T; Hiraoka N
Cancer Sci; 2018 Mar; 109(3):863-870. PubMed ID: 29274107
[TBL] [Abstract][Full Text] [Related]
16. The significance of the co-existence of osteopontin and tumor-associated macrophages in gastric cancer progression.
Lin CN; Wang CJ; Chao YJ; Lai MD; Shan YS
BMC Cancer; 2015 Mar; 15():128. PubMed ID: 25872762
[TBL] [Abstract][Full Text] [Related]
17. Detection of M2 macrophages and colony-stimulating factor 1 expression in serous and mucinous ovarian epithelial tumors.
Kawamura K; Komohara Y; Takaishi K; Katabuchi H; Takeya M
Pathol Int; 2009 May; 59(5):300-5. PubMed ID: 19432671
[TBL] [Abstract][Full Text] [Related]
18. High density of CD204-positive macrophages predicts worse clinical prognosis in patients with breast cancer.
Miyasato Y; Shiota T; Ohnishi K; Pan C; Yano H; Horlad H; Yamamoto Y; Yamamoto-Ibusuki M; Iwase H; Takeya M; Komohara Y
Cancer Sci; 2017 Aug; 108(8):1693-1700. PubMed ID: 28574667
[TBL] [Abstract][Full Text] [Related]
19. Clinical and transcriptional signatures of human CD204 reveal an applicable marker for the protumor phenotype of tumor-associated macrophages in breast cancer.
He Y; Zhou S; Deng F; Zhao S; Chen W; Wang D; Chen X; Hou J; Zhang J; Zhang W; Ding L; Tang J; Zhou Z
Aging (Albany NY); 2019 Dec; 11(23):10883-10901. PubMed ID: 31799941
[TBL] [Abstract][Full Text] [Related]
20. Identification of intravascular tumor microenvironment features predicting the recurrence of pathological stage I lung adenocarcinoma.
Kaseda K; Ishii G; Aokage K; Takahashi A; Kuwata T; Hishida T; Yoshida J; Kohno M; Nagai K; Ochiai A
Cancer Sci; 2013 Sep; 104(9):1262-9. PubMed ID: 23786153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
